Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression
Xiaoqin Yang(Sichuan University), Naofumi Mukaida(Wakayama Medical University), Philip M. Murphy(National Institute of Allergy and Infectious Diseases), Shuichi Kaneko(Kanazawa University), Peirong Lu(Soochow University), Chifumi Fujii(Shinshu University), Yasunari Nakamoto(University of Fukui), Ji‐Liang Gao(National Institutes of Health)
Cited by 103
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
|Journal of Clinical Investigation|2008|822
Alkali-Induced Corneal Neovascularization Is Independent of CXCR2-Mediated Neutrophil Infiltration
|Cornea|2006|814
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573